# Alphabet Inc.: Form 13F holdings

An institutional investment manager in Mountain View, CA. SEC CIK 1652044.

- Quarter ended: 2026-06-30
- Filed: 2026-08-07
- Reported value: $99.08bn
- Positions: 28 (29 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1652044/000165204426000073/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [SPACE EXPLORATION TECHN CORP (SPCX)](/companies/spcx.md) | CLASS A COM STK | $94.18bn | 95.0% | 551,189,500 |  | New +551,189,500 |
| [PLANET LABS PBC (PL)](/companies/pl.md) | COM CL A | $1.17bn | 1.2% | 35,248,893 |  | Unchanged |
| [AST SPACEMOBILE INC (ASTS)](/companies/asts.md) | COM CL A | $794.7m | 0.8% | 8,943,486 |  | Unchanged |
| [CME GROUP INC (CME)](/companies/cme.md) | COM | $769.4m | 0.8% | 3,484,020 |  | Unchanged |
| [ARM HOLDINGS PLC (ARM)](/companies/arm.md) | SPONSORED ADS | $695.2m | 0.7% | 1,960,784 |  | Unchanged |
| [REVOLUTION MEDICINES INC (RVMD)](/companies/rvmd.md) | COM | $551.8m | 0.6% | 2,946,619 |  | Reduced −345,906 |
| [FRESHWORKS INC (FRSH)](/companies/frsh.md) | CLASS A COM | $164.0m | 0.2% | 16,206,643 |  | Unchanged |
| [PARABILIS MEDICINES INC (PBLS)](/companies/pbls.md) | COM | $134.6m | 0.1% | 4,919,498 |  | New +4,919,498 |
| [TEMPUS AI INC (TEM)](/companies/tem.md) | CL A | $89.9m | <0.1% | 1,551,102 |  | Unchanged |
| [GITLAB INC (GTLB)](/companies/gtlb.md) | CLASS A COM | $83.2m | <0.1% | 2,724,712 |  | Unchanged |
| [UIPATH INC (PATH)](/companies/path.md) | CL A | $76.5m | <0.1% | 7,034,337 |  | Unchanged |
| [ETHOS TECHNOLOGIES INC (LIFE)](/companies/life.md) | CL A | $65.7m | <0.1% | 3,622,604 |  | Reduced −147,552 |
| [PRIME MEDICINE INC (PRME)](/companies/prme.md) | COM | $61.1m | <0.1% | 16,562,498 |  | Unchanged |
| [FERVO ENERGY CO (FRVO)](/companies/frvo.md) | CL A COM | $51.5m | <0.1% | 1,760,732 |  | New +1,760,732 |
| [PAYPAY CORP (PAYP)](/companies/payp.md) | SPONSORED ADS | $44.8m | <0.1% | 3,125,000 |  | Unchanged |
| [MAZE THERAPEUTICS INC (MAZE)](/companies/maze.md) | COM | $41.4m | <0.1% | 1,388,583 |  | Unchanged |
| [RELAY THERAPEUTICS INC (RLAY)](/companies/rlay.md) | COM | $26.4m | <0.1% | 1,410,029 |  | Reduced −154,144 |
| [BRIDGEBIO ONCOLOGY THERAPEUT (BBOT)](/companies/bbot.md) | COM NEW | $21.5m | <0.1% | 2,823,126 |  | Unchanged |
| [OSCAR HEALTH INC (OSCR)](/companies/oscr.md) | CL A | $13.7m | <0.1% | 481,988 |  | Unchanged |
| [BEAM THERAPEUTICS INC (BEAM)](/companies/beam.md) | COM | $11.0m | <0.1% | 321,604 |  | Unchanged |
| [VERA THERAPEUTICS INC (VERA)](/companies/vera.md) | CL A | $10.4m | <0.1% | 241,264 |  | Unchanged |
| [SANA BIOTECHNOLOGY INC (SANA)](/companies/sana.md) | COM | $9.8m | <0.1% | 2,812,500 |  | Unchanged |
| [MONTE ROSA THERAPEUTICS INC (GLUE)](/companies/glue.md) | COM | $9.0m | <0.1% | 372,474 |  | Reduced −311,801 |
| [LYELL IMMUNOPHARMA INC (LYEL)](/companies/lyel.md) | COM NEW | $4.1m | <0.1% | 293,256 |  | Unchanged |
| [FIGMA INC (FIG)](/companies/fig.md) | CLASS A COM STK | $3.9m | <0.1% | 215,582 |  | Unchanged |
| [SPERO THERAPEUTICS INC (SPRO)](/companies/spro.md) | COM | $2.0m | <0.1% | 889,979 |  | Unchanged |
| [HYPERFINE INC (HYPR)](/companies/hypr.md) | COM CL A | $1.2m | <0.1% | 898,720 |  | Unchanged |
| [AUTOLUS THERAPEUTICS PLC (AUTL)](/companies/autl.md) | SPON ADS | $1.1m | <0.1% | 698,262 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [TENAYA THERAPEUTICS INC (TNYA)](/companies/tnya.md) | COM | $0 | 0.0% | 0 |  | Sold out −915,705 |

Source: SEC EDGAR, Form 13F-HR, accession 0001652044-26-000073. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.